News
CRISPR is a technology that can be used to edit genes and, as such, will likely change the world. The essence of CRISPR is simple: it’s a way of finding a specific bit of DNA inside a cell. After that ...
The CRISPR gene-editing tool was developed 10 years ago and has since been transformative for research. Here's what to know.
Almost every week there is another scientific/medical advance made using the CRISPR-Cas9 system. Of course, we will continue to bring you news about all of the great ways in which CRISPR-Cas9 can be ...
CRISPR is a versatile tool for editing genomes and has recently been approved as a gene therapy treatment for certain blood disorders.
Everything you need to know about the gene-editing breakthrough that one day could cure disease, eradicate species and build designer babies.
A powerful new gene-editing technology called CRISPR has enormous potential to treat human diseases but the ability to tinker with genes can also be controversial. Here we explain what CRISPR is ...
This little company's scientific breakthrough opened up a whole new sliver of the drug market (although it's still leading ...
A DNA-editing technique called CRISPR keeps popping up in the news, in one medical breakthrough after another. In theory, CRISPR can find any problem area in DNA, snip it out, and replace it with ...
A Chinese scientist claims to have genetically engineered babies using Crispr. Editing DNA could save lives, but many fear unintended consequences.
CRSP is a speculative buy for aggressive investors, driven by the commercial launch and multibillion-dollar potential of ...
CRISPR Therapeutics AG (CRSP) has been one of the most searched-for stocks on Zacks.com lately. So, you might want to look at some of the facts that could shape the stock's performance in the near ...
11d
Zacks.com on MSNInvestors Heavily Search CRISPR Therapeutics AG (CRSP): Here is What You Need to Know
CRISPR Therapeutics (CRSP) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results